ADVFN UK Market News

Author: Fiona Craig

  • Oil Advances as Renewed U.S.-Iran Conflict Revives Fears Over Global Supply

    Oil Advances as Renewed U.S.-Iran Conflict Revives Fears Over Global Supply

    Oil prices moved higher on Thursday after fresh military action between the United States and Iran undermined confidence in a near-term diplomatic resolution and renewed concerns over disruptions to energy flows through the Strait of Hormuz.

    By 05:51 ET (09:51 GMT), Brent crude futures had climbed 2.3% to $96.42 per barrel, while U.S. West Texas Intermediate crude futures gained 2.2% to $90.52 per barrel.

    New Attacks Intensify Tensions Across the Gulf

    Iran’s Islamic Revolutionary Guard Corps said it had launched strikes against a U.S. airbase in Kuwait in retaliation for earlier American attacks on the Iranian port city of Bandar Abbas.

    Separately, Kuwaiti officials confirmed that the country’s air defense systems were responding to incoming missile and drone attacks, although authorities did not identify where the strikes originated.

    The latest exchange marked a renewed escalation in hostilities between Washington and Tehran despite repeated U.S. claims that a fragile ceasefire remained intact. Earlier this week, the United States characterized its strikes on Iranian targets as defensive measures.

    Trump Remarks Reduce Optimism Around Peace Negotiations

    Thursday’s developments came after U.S. President Donald Trump rejected reports suggesting that Iran could reopen commercial shipping routes through the Strait of Hormuz within a month.

    Trump later signaled that he remained unconvinced by current proposals aimed at ending the conflict, which has now stretched into its third month.

    Oil prices had weakened on Wednesday and were also heading for notable weekly losses amid growing market expectations that a diplomatic breakthrough between the U.S. and Iran was close. However, Trump’s latest comments suggested investors may have moved too quickly in pricing in a peace agreement.

    Although U.S. officials had offered encouraging remarks regarding negotiations with Tehran over the past week, major disagreements persisted over Iran’s nuclear programme and future arrangements surrounding the Strait of Hormuz.

    Shipping Disruptions Continue to Affect Energy Markets

    Recent shipping data indicated that some vessels had resumed passing through the Strait of Hormuz, although overall traffic volumes remained significantly below pre-conflict levels.

    Ongoing disruption around the strategic passage continues to impact roughly 20% of global oil supplies, leaving energy markets highly sensitive to any further escalation.

    Trump also dismissed proposals for Iran and Oman to jointly oversee the waterway, arguing that such an important global shipping route should not fall under the control of any single nation.

    Analysts Warn of Increasing Pressure on the Oil Industry

    Analysts at Yardeni Research cautioned that both Iran and the wider global oil market were approaching increasingly vulnerable conditions.

    “If an agreement is reached, it may be because the oil market is approaching a dangerous stage for both Iran and the global oil industry. Iran faces a lack of oil storage that could force it to shut down oil production, and the global oil industry is running on such slim supplies that it could start affecting pipelines and other oil infrastructure,” analysts at Yardeni Research said in a note to clients.

  • Gold Drops Sharply as U.S.-Iran Conflict Revives Inflation and Rate Concerns

    Gold Drops Sharply as U.S.-Iran Conflict Revives Inflation and Rate Concerns

    Gold prices retreated on Thursday, falling to their lowest level in two months as escalating tensions between the United States and Iran drove oil prices higher and renewed fears of persistent inflationary pressures.

    At 05:33 ET (09:33 GMT), spot gold was down 1.4% at $4,392.88 per ounce, while gold futures declined 1.3% to $4,423.37 per ounce. The latest move pushed spot prices below the key $4,400-per-ounce threshold, breaking out of the broad $4,400 to $4,600 range that had remained largely intact since mid-May.

    Renewed Military Action Pressures Safe-Haven Demand

    Iran’s Islamic Revolutionary Guard Corps said it had targeted a U.S. airbase in Kuwait in retaliation for earlier American strikes against the Iranian port city of Bandar Abbas.

    Separately, Kuwaiti officials confirmed that the country’s defense systems intercepted incoming missiles and drones, although authorities did not specify who launched the attacks.

    The renewed exchange of strikes highlighted the fragile state of relations between Washington and Tehran despite repeated U.S. claims that a ceasefire remained in place. Earlier this week, the United States characterized its attacks on Iran as defensive operations.

    Thursday’s escalation also followed comments from U.S. President Donald Trump, who rejected reports suggesting Iran could reopen commercial shipping routes through the Strait of Hormuz within weeks. Trump later indicated that he remained dissatisfied with current efforts to secure a peace agreement aimed at ending the nearly three-month-long conflict.

    Higher Oil Prices Reinforce Inflation Fears

    Crude oil prices advanced again following the latest developments, remaining below the $100-per-barrel mark but still significantly above levels seen before the conflict began.

    Investors continue to worry that sustained increases in energy prices could fuel another global inflation surge, potentially forcing central banks to tighten monetary policy further through additional interest rate hikes.

    That outlook tends to weigh on gold, which offers no yield and often loses appeal during prolonged periods of elevated interest rates.

    “Rates markets are still displaying elevated central bank pricing,” analysts at ING said in a note.

    Markets Focus on Upcoming U.S. PCE Inflation Data

    Attention is now turning toward Thursday’s release of the U.S. personal consumption expenditures (PCE) price index for April, a key inflation measure closely monitored by the Federal Reserve.

    Analysts expect annual headline PCE inflation to rise to 3.8% from 3.5%, while the monthly reading is projected to slow to 0.5% from 0.7%.

    Core PCE inflation, which strips out food and energy prices, is forecast to edge up to 3.3% year-on-year while remaining unchanged at 0.3% on a monthly basis.

    The PCE index remains one of the Federal Reserve’s preferred gauges for tracking inflation, and recent comments from Fed officials have underscored growing disagreements within the central bank over the future path of interest rates.

  • Wall Street Futures Weaken as Renewed U.S.-Iran Conflict Clouds Market Outlook: Dow Jones, S&P, Nasdaq

    Wall Street Futures Weaken as Renewed U.S.-Iran Conflict Clouds Market Outlook: Dow Jones, S&P, Nasdaq

    U.S. equity futures traded lower on Thursday, while oil prices advanced, after a fresh round of military strikes between the United States and Iran reignited concerns over stability in the Gulf and reduced optimism surrounding a possible peace agreement. Investors were also focused on upcoming U.S. inflation data closely watched by the Federal Reserve.

    At 03:37 ET, futures tied to the Dow Jones Industrial Average were down 53 points, or 0.1%. S&P 500 futures declined 11 points, also down 0.1%, while Nasdaq 100 futures lost 99 points, equivalent to 0.3%.

    The weaker tone followed a relatively positive session on Wall Street the previous day, when major indices managed modest gains amid lingering expectations that diplomatic talks between Washington and Tehran could still progress.

    Analysts at Vital Knowledge said markets continue to price in the possibility that a resolution to the conflict may emerge soon. However, sentiment deteriorated after the White House rejected as “a complete fabrication” reports aired by Iranian state television regarding an alleged draft Memorandum of Understanding.

    Consumer Shares Hold Up While Energy and Tech Stocks Lose Momentum

    Earlier support for equities had come from softer Brent crude prices and stronger-than-anticipated earnings from retailers including Abercrombie & Fitch and Bath & Body Works.

    Vital Knowledge analysts said those developments, together with what they described as “sanguine” commentary from companies attending a major investor conference, helped support consumer discretionary stocks.

    At the same time, energy stocks came under pressure, while investors locked in gains from several high-performing technology shares that had rallied sharply in recent weeks.

    Escalating Military Action Raises Concerns Over Ceasefire Durability

    Geopolitical tensions intensified again after reports emerged that the U.S. military conducted additional strikes inside Iran on Wednesday following Iranian drone attacks against commercial shipping in the Strait of Hormuz.

    According to the Wall Street Journal, citing officials familiar with the situation, U.S. forces destroyed a drone and targeted a drone-control facility near the Iranian port city of Bandar Abbas.

    A U.S. official told Reuters that the operations were “measured, purely defensive and intended to maintain” the fragile ceasefire currently in place.

    Iran’s Islamic Revolutionary Guard Corps later claimed responsibility for strikes against a U.S. military base and warned that any additional attacks would trigger retaliation.

    Meanwhile, Kuwait’s military confirmed that it had intercepted incoming drones and missiles, ending a period of relative calm that had lasted for several weeks.

    Oil Prices Advance as Supply Risks Remain Elevated

    Efforts to secure a diplomatic solution to the conflict continued but failed to produce an immediate breakthrough, with negotiations still hindered by disagreements over Iran’s nuclear programme and tensions surrounding the Strait of Hormuz.

    Against that backdrop, Brent crude climbed 2.8% to $96.95 per barrel. Although prices remained below the psychologically important $100 level, they continued to trade significantly above pre-conflict levels.

    Disruptions around the Strait of Hormuz have fuelled concerns about global energy supplies, helping to drive oil prices higher and increasing fears of renewed inflationary pressure worldwide. Roughly one-fifth of global oil and liquefied natural gas shipments pass through the strategic waterway.

    Investors Await Key U.S. Inflation Reading

    Attention is now turning toward the release of the U.S. personal consumption expenditures (PCE) price index for April, one of the Federal Reserve’s preferred measures of inflation.

    Economists expect annual headline PCE inflation to accelerate to 3.8% from 3.5%, while the monthly reading is forecast to ease to 0.5% from 0.7%.

    Core PCE inflation, which excludes food and energy prices, is projected to edge up to 3.3% year-on-year while remaining unchanged month-on-month at 0.3%.

    Recent remarks from Federal Reserve officials have highlighted growing divisions within the central bank over the future direction of interest rates, particularly amid concerns about the inflationary impact of rising energy costs.

    Markets are increasingly pricing in the possibility that the Fed and other major central banks may need to resume rate hikes if inflation pressures continue to build.

    Musk Clarifies Terms of SpaceX-Anthropic Computing Partnership

    Separately, Elon Musk said Thursday evening that SpaceX’s agreement with artificial intelligence startup Anthropic to provide computing capacity is currently based on a short-term arrangement rather than a multi-year commitment.

    Earlier disclosures from SpaceX had suggested the agreement would give Anthropic access to computing resources at the Colossus data centre through May 2029.

    Responding to social media commentary, Musk said “SpaceX has not committed to leasing Colossus for years, although it’s possible that may be what happens.”

    He added that the deal currently consists of a 180-day lease with a 90-day mutual cancellation clause thereafter. According to Musk, SpaceX specifically requested the shorter-term structure to preserve flexibility in case the company later requires additional internal computing resources.

  • European Markets Retreat as Gulf Conflict Intensifies: DAX, CAC, FTSE100

    European Markets Retreat as Gulf Conflict Intensifies: DAX, CAC, FTSE100

    European equities opened lower on Thursday as renewed military tensions in the Gulf raised concerns over the stability of the fragile ceasefire between the United States and Iran, while also clouding prospects for a broader diplomatic agreement between the two countries.

    At 07:02 GMT, the pan-European Stoxx 600 index had declined 0.4%. Germany’s DAX fell 0.5%, France’s CAC 40 slipped 0.4%, and the FTSE 100 in London dropped 0.7%.

    Fresh Military Strikes Renew Investor Concerns

    Investor sentiment weakened after reports that the U.S. military launched additional strikes inside Iran on Wednesday, following Iranian drone attacks targeting commercial vessels in the Strait of Hormuz.

    According to the Wall Street Journal, citing officials familiar with the matter, U.S. forces destroyed a drone and targeted a drone-control facility near the southern Iranian port city of Bandar Abbas.

    Iran’s Islamic Revolutionary Guard Corps later stated that it had retaliated by striking a U.S. military base and warned that any future attacks would trigger further responses.

    Diplomatic Efforts Continue Without Breakthrough

    Despite the latest escalation, diplomatic discussions aimed at ending the conflict continued, although negotiators failed to secure an immediate breakthrough in talks surrounding the nearly three-month-long crisis.

    Elsewhere in the region, Kuwait’s military reported intercepting incoming missiles and drones, ending what had previously been a relatively calm period lasting several weeks without direct attacks.

    Oil Prices Climb on Supply Concerns

    Energy markets reacted to the growing instability, with Brent crude futures rising 2.6% to $96.72 per barrel.

    Although oil prices remained below the symbolic $100-per-barrel level, they continue to trade significantly above levels seen before the conflict began.

  • FTSE 100 Falls as Renewed U.S.-Iran Attacks Undermine Ceasefire Optimism

    FTSE 100 Falls as Renewed U.S.-Iran Attacks Undermine Ceasefire Optimism

    British equities moved lower on Thursday, tracking declines across European markets after a renewed exchange of military strikes between the United States and Iran weakened hopes for a diplomatic breakthrough in the Middle East. Investor sentiment was also pressured by warnings from the European Central Bank that energy-driven inflation risks may remain elevated for longer than markets currently expect.

    By 07:26 GMT, the FTSE 100 had dropped 0.92%, while Germany’s DAX declined 0.34% and France’s CAC 40 slipped 0.41%. Sterling also weakened slightly, falling 0.18% against the U.S. dollar to $1.3402.

    Fresh Military Escalation Raises Regional Tensions

    Market anxiety intensified after the U.S. military confirmed it had carried out new defensive strikes near Bandar Abbas on Wednesday. According to U.S. officials, the operation targeted a ground control station believed to be preparing drone launches against commercial and military vessels operating in the Strait of Hormuz.

    Iran’s Revolutionary Guards responded early Thursday, claiming they had struck the U.S. air base used to launch the attack. Kuwait later reported that its air defence systems had intercepted missiles and drones, marking one of the most direct exchanges between the two sides in recent days.

    Diplomatic Progress Overshadowed by Conflict

    The latest military escalation overshadowed earlier signs that diplomatic efforts might be gaining traction.

    Speaking during a Cabinet meeting, U.S. President Donald Trump said Iran was “negotiating on fumes,” while adding, “maybe we have to go back and finish it, maybe we don’t.”

    Secretary of State Marco Rubio also indicated there had been “progress and interest” toward a possible agreement, stressing that diplomacy remained Washington’s preferred course of action.

    Meanwhile, the White House dismissed Iranian state television reports claiming that a draft “Islamabad Framework” agreement existed under which Tehran would oversee shipping transit through the Strait of Hormuz, describing the report as “a complete fabrication.”

    Tehran Maintains Hard-Line Position

    Further uncertainty emerged from comments made by senior Iranian officials.

    Iran’s Supreme National Security Council stated that the country’s enriched uranium stockpile remained outside the scope of negotiations, while a senior Iranian lawmaker warned that even a U.S. agreement “would not mean the end of the war.”

    Deputy foreign minister Ali Bagheri Kani also reiterated demands that all frozen Iranian assets be returned “fully and unconditionally,” a condition that President Trump has already rejected.

    ECB Warns Energy Inflation Could Persist

    Adding to investor concerns, ECB chief economist Philip Lane warned on Thursday that the energy shock linked to Middle East tensions could continue affecting inflation even if the conflict is resolved relatively quickly.

    Speaking at a conference hosted by the Bank of Japan and its affiliated think tank in Tokyo, Lane cautioned about potential “second-round effects” as countries seek to rebuild energy reserves and diversify supply chains.

    Financial markets are currently pricing in two additional ECB interest rate hikes, while expectations for a third increase remain roughly balanced.

  • Market Open: SSE Infrastructure Spending, Johnson Matthey Cash Flow

    Market Open: SSE Infrastructure Spending, Johnson Matthey Cash Flow

    FTSE 100 falls as Gulf tensions lift Brent crude, while SSE boosts infrastructure investment and Johnson Matthey beats cash flow estimates.

    Market Overview

    European markets traded lower amid renewed geopolitical tensions in the Gulf region after reports of fresh US-Iran strike exchanges weakened hopes of a ceasefire. The FTSE 100 fell 0.80 per cent to 10,406.44, while the DAX slipped 0.03 per cent and the S&P 500 lost 0.31 per cent. The Nasdaq also moved lower as investors monitored escalating tensions alongside concerns over energy supply disruption and broader global growth risks.

    Commodity markets reflected the heightened uncertainty, with Brent crude climbing above $94 per barrel on fears surrounding the Strait of Hormuz and supply flows. Gold remained supported by demand for defensive assets, while Bitcoin weakened against sterling as broader risk appetite softened. Sterling traded weaker against most major currencies, with investors also assessing the outlook for inflation and central bank policy amid rising energy prices.

    Market Numbers

    FTSE 100: Down (-0.80%), 10,406.44
    CAC40: Up (0.43%), 8,207.890
    DAX: Down (-0.03%), 25,177.80
    NASDAQ: Down (-0.36%), 29,880.0
    S&P 500: Down (-0.31%), 7,515.0

    In the Headlines

    Infrastructure Expansion – SSE (LSE:SSE)
    SSE accelerated infrastructure spending plans to support long-term growth tied to the energy transition, with investment focused on electricity networks and renewable energy projects. The move highlights continued demand for grid upgrades and clean energy infrastructure across the UK.

    Cash Flow Growth – Johnson Matthey (LSE:JMAT)
    Johnson Matthey reported that FY26 free cash flow more than doubled and exceeded analyst expectations, supported by operational improvements and stronger business performance. The update may strengthen investor confidence in the company’s restructuring and capital allocation strategy.

    Currencies (vs GBP)

    USD: Down (-0.13%), $1.3402
    CHF: Down (-0.10%), Fr.1.05594
    EUR: Down (-0.04%), €1.1538
    JPY: Down (-0.20%), ¥213.782
    AUD: Up (0.16%), $1.881840
    Bitcoin (BTC/GBP): Down (-1.49%), £54,578.6

    Commodities

    Copper: Down (0.35%), 6.34338
    Gold: Down (1.42%), 4,392.96
    Brent Crude: Up (2.35%), 94.61
    Natural Gas: Down (-0.26%), 3.072

  • SkinBioTherapeutics Finalises Financial Investigation and Appoints New Auditor Ahead of Results Publication (SBTX)

    SkinBioTherapeutics Finalises Financial Investigation and Appoints New Auditor Ahead of Results Publication (SBTX)

    SkinBioTherapeutics (LSE:SBTX) said its board has completed an investigation into the company’s financial statements for the year ended 30 June 2025 and is preparing to publish its delayed interim HY26 results together with restated, unaudited FY25 accounts.

    The company noted that trading in its shares, which remains suspended, is expected to resume once the outstanding financial information and related remedial measures have been released. Publication has taken longer than initially anticipated, extending beyond the original end-May timetable due to challenges encountered while gathering supporting evidence during the review process.

    New Auditor Appointed Following Tender Process

    Alongside the update, SkinBioTherapeutics confirmed the appointment of Saffrey LLP as its new independent auditor for the financial year ending 30 June 2026. The appointment follows a formal competitive tender exercise conducted by the board.

    Outgoing auditor Gravita Audit II Limited stated that there were no matters requiring attention from shareholders or creditors in connection with its departure. The company said this confirmation should help support efforts to rebuild investor confidence in its financial reporting standards and corporate governance procedures.

    Governance Improvements Follow Period of Uncertainty

    Management is aiming to restore stability following the accounting review and share suspension, with the upcoming publication of revised results expected to provide greater clarity on the company’s financial position and future direction.

    The company’s outlook is held back primarily by ongoing unprofitability and weak cash flows, despite strong revenue growth and a relatively conservative balance sheet. Technicals also remain bearish with the stock trading below major moving averages and negative MACD, while valuation is constrained by losses (negative P/E) and no dividend yield support.

    More about SkinBioTherapeutics

    SkinBioTherapeutics is a UK-based life science company focused on skin health, built around its proprietary SkinBiotix platform developed with the University of Manchester. Its core business targets the skin healthcare market across five pillars, led by cosmetic skincare via partner Croda’s Zenakine-branded actives and AxisBiotix food supplements for inflammatory skin conditions, sold online, on Amazon and through selected Superdrug stores.

    The group is also pursuing a consolidator strategy, acquiring complementary skincare and cosmetic businesses that add distribution reach, geographic presence and manufacturing capability to support its in-house product pillars. SkinBioTherapeutics has been listed on London’s AIM market since April 2017 and is headquartered in Newcastle, positioning it within the UK’s specialist life sciences and dermatology ecosystem.

  • IQE Strengthens Balance Sheet With £81 Million Fundraise as AI Photonics Demand Expands (IQE)

    IQE Strengthens Balance Sheet With £81 Million Fundraise as AI Photonics Demand Expands (IQE)

    IQE (LSE:IQE) reported full-year 2025 revenue of £97.3 million, representing a decline of 17.6% compared with the previous year, as weaker smartphone demand and wider macroeconomic uncertainty weighed on its wireless division. In contrast, photonics revenue increased 15%, driven by stronger demand from defence applications and AI-focused data-centre infrastructure.

    Adjusted EBITDA declined to £3.2 million during the period, although the company improved operating cash flow and reduced capital expenditure as part of ongoing efficiency measures. IQE also continued investing in gallium nitride (GaN) and microLED production capabilities while further optimising its global manufacturing operations.

    Strategic Investment Reshapes Financial Position

    A recently completed £81 million fundraising has significantly strengthened the company’s balance sheet. The financing included a £45 million strategic investment alongside long-term supply agreements with MACOM.

    Following completion of the transaction, IQE repaid its revolving credit facility and reported net cash inflows of £27.9 million, improving financial flexibility and liquidity.

    Management said the strengthened balance sheet will support future growth initiatives while allowing the business to capitalise on increasing demand across high-growth semiconductor markets.

    AI and Data-Centre Demand Drives 2026 Momentum

    The company reported strong trading momentum entering 2026, with accelerating demand for indium phosphide (InP) photonics products used in AI infrastructure and data-centre applications. IQE also highlighted solid order activity from aerospace, defence and smartphone customers.

    Based on current trading conditions, management expects revenue growth of more than 20% in 2026 and anticipates a return to high single-digit to low double-digit EBITDA margins as operational leverage improves.

    Financial Challenges Still Influence Valuation

    The company’s outlook is held down primarily by weak financial performance (negative profitability and deteriorating cash flow) and a loss-making valuation profile (negative P/E). This is partially offset by strong recent technical momentum, with the price trading above key moving averages and positive MACD.

    More about IQE plc

    IQE plc, based in Cardiff, is a leading global supplier of compound semiconductor wafer products and advanced material solutions. The group focuses on photonics, wireless, power and display applications, serving fast-growing markets such as AI-driven data centres, aerospace and defence, consumer smartphones, automotive sensing and emerging microLED displays.

  • Petro Matad Moves Closer to PetroChina Sales Agreement While Expanding Renewable Energy Ambitions (MATD)

    Petro Matad Moves Closer to PetroChina Sales Agreement While Expanding Renewable Energy Ambitions (MATD)

    Petro Matad (LSE:MATD) said approval of its 2026 Oil Sales Agreement with PetroChina is expected shortly, paving the way for the sale of approximately 35,000 barrels of accumulated oil production from Block XX. The company expects the agreement to allow sales at current higher market prices, potentially improving near-term cash generation.

    Production from the Heron-1 and Gazelle-1 wells continues to perform in line with or above company expectations. Management also noted that operating costs have remained under control despite increased production volumes across the field operations.

    Alongside ongoing production activity, Petro Matad is evaluating a potential near-term 3D seismic survey programme aimed at improving reservoir understanding and supporting future appraisal and development drilling plans.

    Partner Discussions and Renewable Expansion Continue

    The company said farm-out negotiations relating to Block XX and Block VII have progressed more slowly than initially anticipated. However, stronger oil prices have recently generated renewed interest from prospective partners, widening Petro Matad’s strategic options.

    Beyond hydrocarbons, the group is continuing to expand its renewable energy business through SunSteppe Renewable Energy. The division is advancing plans for a 200MW hybrid power project and is also participating in tenders or early-stage discussions for several additional solar, wind and battery storage developments ranging between 90MW and 100MW.

    Management believes these projects position the company to benefit from Mongolia’s growing demand for renewable and grid-stabilising energy infrastructure as the country accelerates its energy transition strategy.

    Operational Updates and Shareholder Engagement

    Petro Matad also confirmed arrangements for its upcoming Annual General Meeting in Ulaanbaatar, with shareholders able to participate either in person or remotely. The company said further updates are expected as the PetroChina sales agreement progresses, seismic plans advance and renewable project opportunities develop further.

    Financial Outlook Remains Mixed

    The company’s outlook is held back primarily by very weak profitability and consistently negative (and worsening) free cash flow, despite sharp revenue growth. A strong, low-debt balance sheet provides an important offset, while technical signals are mixed/neutral and valuation remains challenging due to losses and lack of dividend data.

    More about Petro Matad

    Petro Matad Limited is an AIM-quoted oil and gas company focused on exploration and production in Mongolia, primarily through its Block XX and Block VII licences. The group also has a growing presence in renewable energy via its SunSteppe Renewable Energy arm, which is developing large-scale hybrid wind, solar and battery storage projects to support Mongolia’s power grid and energy transition.

  • OptiBiotix Improves Revenue and Margins as Focus Shifts Toward Sustainable Profitability (OPTI)

    OptiBiotix Improves Revenue and Margins as Focus Shifts Toward Sustainable Profitability (OPTI)

    OptiBiotix Health (LSE:OPTI) reported strong financial progress for 2025, with revenue increasing 34% to £1.17 million and gross profit climbing 85% to £614,000. Gross margins also improved significantly to 53%, supported by continued expansion in international markets, particularly across Asia, which now contributes 73% of total group revenue.

    The company ended the year with cash reserves of £1.04 million and no debt, while its listed shareholdings in ProBiotix Health and SkinBioTherapeutics were valued at approximately £6.45 million. OptiBiotix also carried forward an additional £212,000 of customer orders into the 2026 financial year.

    International Expansion and Product Development Drive Momentum

    Operationally, the business continued expanding the commercial reach of its SlimBiome weight-management ingredient, including its launch within the Hydroxycut brand in the United States. The company also secured a new distribution agreement with a major direct-selling weight management company and reported rapid growth across Asian markets, where 17 products have now launched.

    OptiBiotix additionally introduced an upgraded enzyme-based production process for SweetBiotix, designed to improve manufacturing yields, reduce costs and enhance taste performance. Alongside this, its WellBiome platform is being evaluated in a hospital-led clinical study examining potential reductions in intensive care stays and healthcare costs.

    Record Order Intake Supports 2026 Outlook

    The company entered 2026 with strong commercial momentum, reporting record order intake early in the year. This included a 24-tonne SlimBiome order in Taiwan and total January orders exceeding £800,000.

    Management said its strategic priorities are now evolving from rapid expansion toward achieving commercial sustainability and improved profitability. Planned measures include annual cost reductions of between £500,000 and £600,000, lower SlimBiome production expenses and the introduction of dedicated business-unit profit and loss accountability by the end of 2026.

    Financial Challenges Still Influence Outlook

    The company’s outlook is weighed down primarily by persistent losses and cash burn despite strong 2024 revenue growth, and by weak technicals showing a sustained downtrend with negative momentum. A debt-free balance sheet provides some support, but valuation remains difficult to justify with negative earnings and no dividend yield provided.

    More about OptiBiotix Health

    OptiBiotix Health is a UK-listed life sciences company focused on microbiome-based ingredients and products designed to reduce hunger and food cravings, improve gut health and offer sweet fibre sugar substitutes. Its core portfolio includes prebiotic brands such as SlimBiome, WellBiome, SweetBiotix and Microbiome Modulators, complemented by interests in skincare and probiotics via stakes in SkinBioTherapeutics and ProBiotix Health.